[go: up one dir, main page]

AR029758A1 - Un derivado del grupo a de las estreptograminas, su preparacion y las composiciones farmaceuticas que los contienen - Google Patents

Un derivado del grupo a de las estreptograminas, su preparacion y las composiciones farmaceuticas que los contienen

Info

Publication number
AR029758A1
AR029758A1 ARP000103367A ARP000103367A AR029758A1 AR 029758 A1 AR029758 A1 AR 029758A1 AR P000103367 A ARP000103367 A AR P000103367A AR P000103367 A ARP000103367 A AR P000103367A AR 029758 A1 AR029758 A1 AR 029758A1
Authority
AR
Argentina
Prior art keywords
preparation
group
pharmaceutical compositions
compositions containing
streptograms
Prior art date
Application number
ARP000103367A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR029758(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR029758A1 publication Critical patent/AR029758A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06182—Dipeptides with the first amino acid being heterocyclic and Pristinamycin II; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se revelan derivados del grupo A de las estreptograminas de formula general (1) en la que: R1 representa un átomo de halogeno o un radical ácido o tiocianato. R2 representa un átomo de hidrogeno un radical metilo o etilo. R3 representa un átomo de hidrogeno, o el resto de un éster alifático, ciclo-alifático, aromático, aralifático, heterocíclico o heterocíclilalifático que puede ser sustituido, y la línea punteada representa una union simple (estereoquímica 27R) o una union doble, así como sus sales cuando existen. También se describe la preparacion de dichos compuestos y las composiciones farmacéuticas que los contienen.
ARP000103367A 1999-06-30 2000-06-30 Un derivado del grupo a de las estreptograminas, su preparacion y las composiciones farmaceuticas que los contienen AR029758A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908375A FR2795733B1 (fr) 1999-06-30 1999-06-30 Derives de streptogramines, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
AR029758A1 true AR029758A1 (es) 2003-07-16

Family

ID=9547496

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP000103367A AR029758A1 (es) 1999-06-30 2000-06-30 Un derivado del grupo a de las estreptograminas, su preparacion y las composiciones farmaceuticas que los contienen
ARP080102448A AR066926A2 (es) 1999-06-30 2008-06-06 Composicion farmaceutica que comprende un derivado del grupo a de las estreptograminas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP080102448A AR066926A2 (es) 1999-06-30 2008-06-06 Composicion farmaceutica que comprende un derivado del grupo a de las estreptograminas

Country Status (37)

Country Link
US (2) US6569854B1 (es)
EP (1) EP1187847B1 (es)
JP (1) JP4585728B2 (es)
KR (1) KR100742035B1 (es)
CN (2) CN100543032C (es)
AP (1) AP1392A (es)
AR (2) AR029758A1 (es)
AT (1) ATE255592T1 (es)
AU (1) AU781923B2 (es)
BG (1) BG65786B1 (es)
BR (1) BRPI0012032B1 (es)
CA (1) CA2376698C (es)
CZ (1) CZ301048B6 (es)
DE (1) DE60006958T2 (es)
DK (1) DK1187847T3 (es)
EA (1) EA005199B1 (es)
EE (1) EE04683B1 (es)
ES (1) ES2207535T3 (es)
FR (1) FR2795733B1 (es)
GE (1) GEP20063972B (es)
HR (1) HRP20010937B1 (es)
HU (1) HUP0201692A3 (es)
IL (2) IL146185A0 (es)
MA (1) MA26802A1 (es)
MX (1) MXPA01012807A (es)
NO (1) NO329456B1 (es)
NZ (1) NZ516100A (es)
OA (1) OA11979A (es)
PT (1) PT1187847E (es)
RS (1) RS50138B (es)
SI (1) SI1187847T1 (es)
SK (1) SK285605B6 (es)
TN (1) TNSN00145A1 (es)
TR (1) TR200103829T2 (es)
UA (1) UA71619C2 (es)
WO (1) WO2001002427A1 (es)
ZA (1) ZA200110150B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775288B1 (fr) * 1998-02-26 2000-03-31 Rhone Poulenc Rorer Sa Derives de streptogramines, leur preparation et les compositons qui les contiennent
FR2795733B1 (fr) * 1999-06-30 2001-09-07 Aventis Pharma Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
US7232799B2 (en) 2000-12-21 2007-06-19 Aventis Pharma Sa Streptogramin derivatives and compositions thereof
US6596717B2 (en) 2000-12-21 2003-07-22 Aventis Pharma S.A. Streptogramin derivatives, their preparation and compositions which contain them
US7488747B2 (en) 2003-12-29 2009-02-10 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
US7565200B2 (en) * 2004-11-12 2009-07-21 Advanced Neuromodulation Systems, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects
CN101394847B (zh) 2006-01-06 2017-05-24 塞普拉柯公司 作为单胺重摄取抑制剂的环烷基胺类
CA2636275C (en) 2006-01-06 2013-02-12 Sepracor Inc. Tetralone-based monoamine reuptake inhibitors
JP5377285B2 (ja) 2006-03-31 2013-12-25 サノビオン ファーマシューティカルズ インク キラルアミドおよびキラルアミンの調製
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
CN103936605B (zh) 2007-05-31 2017-09-01 赛诺维信制药公司 苯基取代的环烷胺作为一元胺再摄取抑制剂
CN103508981A (zh) * 2012-06-18 2014-01-15 北京美倍他药物研究有限公司 新的哌嗪衍生物及其医药用途
CA3070851A1 (en) * 2017-08-01 2019-02-07 The Regents Of The University Of California Methods of making streptogramin compositions and the use thereof
KR102107659B1 (ko) 2018-12-07 2020-05-07 경상대학교 산학협력단 Mmagnu1 화합물을 유효성분으로 함유하는 결핵균 또는 비결핵 항산균 감염 질환 예방 또는 치료용 조성물
AU2021279243A1 (en) 2020-05-27 2023-01-05 Fondazione Giovanni Celeghin - Onlus New therapy for the treatment of tumors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
BE1001013A4 (fr) * 1987-10-22 1989-06-13 Icp Internat Inst Of Cellular Derives de synergimycines de types a et b, procede pour leur preparation et utilisation de ceux-ci.
IL121821A (en) * 1993-02-17 2000-02-17 Rhone Poulenc Rorer Sa Process for purifying a group A minority component of streptogramin some such purified components and their uses
FR2766489B1 (fr) * 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
FR2795733B1 (fr) * 1999-06-30 2001-09-07 Aventis Pharma Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent

Also Published As

Publication number Publication date
CA2376698A1 (fr) 2001-01-11
FR2795733A1 (fr) 2001-01-05
DE60006958D1 (de) 2004-01-15
EE04683B1 (et) 2006-08-15
EP1187847B1 (fr) 2003-12-03
CN100543032C (zh) 2009-09-23
UA71619C2 (uk) 2004-12-15
ZA200110150B (en) 2003-03-10
EE200100706A (et) 2003-04-15
HRP20010937A2 (en) 2003-08-31
KR20020020763A (ko) 2002-03-15
DK1187847T3 (da) 2004-01-05
US20030149004A1 (en) 2003-08-07
RS50138B (sr) 2009-03-25
CN1961878A (zh) 2007-05-16
YU89501A (sh) 2004-05-12
MA26802A1 (fr) 2004-12-20
TR200103829T2 (tr) 2002-04-22
OA11979A (fr) 2006-04-18
NZ516100A (en) 2004-01-30
DE60006958T2 (de) 2004-10-21
HUP0201692A3 (en) 2002-10-28
NO329456B1 (no) 2010-10-25
JP4585728B2 (ja) 2010-11-24
AR066926A2 (es) 2009-09-23
EP1187847A1 (fr) 2002-03-20
BG65786B1 (bg) 2009-11-30
EA200200108A1 (ru) 2002-06-27
KR100742035B1 (ko) 2007-07-23
HUP0201692A2 (en) 2002-09-28
IL146185A0 (en) 2002-07-25
SK285605B6 (sk) 2007-04-05
CZ20014641A3 (cs) 2002-04-17
CN1358194A (zh) 2002-07-10
IL146185A (en) 2007-08-19
ES2207535T3 (es) 2004-06-01
PT1187847E (pt) 2004-04-30
BRPI0012032B1 (pt) 2015-06-30
WO2001002427A1 (fr) 2001-01-11
BG106235A (en) 2002-08-30
AP2001002371A0 (en) 2001-12-31
SI1187847T1 (en) 2004-04-30
GEP20063972B (en) 2006-11-27
CA2376698C (fr) 2013-05-14
ATE255592T1 (de) 2003-12-15
AU6288600A (en) 2001-01-22
US7166594B2 (en) 2007-01-23
NO20016247L (no) 2002-02-08
NO20016247D0 (no) 2001-12-19
AP1392A (en) 2005-04-15
AU781923B2 (en) 2005-06-23
MXPA01012807A (es) 2002-07-22
HRP20010937B1 (en) 2005-02-28
PL352781A1 (en) 2003-09-08
CZ301048B6 (cs) 2009-10-21
FR2795733B1 (fr) 2001-09-07
JP2003503509A (ja) 2003-01-28
BR0012032A (pt) 2002-03-19
TNSN00145A1 (fr) 2002-05-30
EA005199B1 (ru) 2004-12-30
US6569854B1 (en) 2003-05-27
SK19302001A3 (sk) 2002-07-02

Similar Documents

Publication Publication Date Title
AR029758A1 (es) Un derivado del grupo a de las estreptograminas, su preparacion y las composiciones farmaceuticas que los contienen
AR047076A1 (es) Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas
AR088808A2 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
PE20050867A1 (es) DERIVADOS DE PIPERAZINA COMO INHIBIDORES DE LA INTERACCION DE gp 120 CON CD4
YU45095A (sh) Derivati benzimidazola, postupci za njihovo prirpremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
AR033499A1 (es) Derivado de quinazolina, proceso para su preparacion, composicion farmaceutica que lo comprende y su uso en la fabricacion de medicamentos para usar en la produccion de un efecto antiangeogenico y/o reductor de la permeabilidad vascular en un animal de sangre caliente
PA8495101A1 (es) Derivados de 13-metileritromicina
GT200600134A (es) Compuestos novedosos de derivados de aminosulfonilo
AR023971A1 (es) Derivados de 4,5,6,7-tetrahidroindazol, procedimiento para la preparacion de los mismos y su utilizacion como agentes antitumorales
CY1106679T1 (el) Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα
UY28578A1 (es) Derivados de amida
AR059248A1 (es) Heterociclos nitrogenados y sus usos como inhibidores de aterosclerosis. composiciones farmaceuticas
CY1116183T1 (el) Πιπεραζινοδιονες ως ανταγωνιστες υποδοχεα οξυτοκινης
AR074053A1 (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), y composiciones farmaceuticas que los contienen
AR042733A1 (es) Derivados de piridinas utilizados como inhibidores del mecanismo de intercambio na+/ca2+
PE20040698A1 (es) Derivados de isoindolina
UY28536A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
CL2021003594A1 (es) Derivados de 3,6-diamino-piridazin-3-ilo, composiciones farmacéuticas que los contienen y sus usos como agentes proapoptóticos.
BR0111678A (pt) Composições medicinais contendo derivados de propenona
UY29739A1 (es) Derivados de amidas o sales farmacéuticamente aceptables de los mismos, procesos de preparaciones farmacéuticas conteniéndolos y aplicaciones
AR052370A1 (es) Tiazolidinonas y su uso como inhibidores de la poloquinasa(plk)
AR006719A1 (es) Derivados de bencilamina y formulacion farmaceutica que comprende a uno de dichos derivados.
HRP20010630B1 (en) 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
DK0880520T3 (da) Benzo[c]quinolinderivater, deres fremstilling af anvendelse som 5-alfa-reduktaseinhibitorer

Legal Events

Date Code Title Description
FG Grant, registration